INS and type 2 diabetes mellitus: Low doses (20 μg/kg) and diminished exposure to NDEA have been shown to cause type 2 diabetes mellitus (T2DM), cognitive impairments, and Alzheimer’s disease (AD)-type neurodegeneration with peripheral and cerebral insulin resistance in animal models [16,17].